company

GOLDMED AS

3045 DRAMMEN

Return on Equity
70,69 %
Current Ratio
1,59
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue1 711 000
Net Income123 000
Total Assets469 000
Total Equity174 000
Income (NOK)2022
Revenue1 711 000
Expenditure1 589 000
Operating Profit122 000
Financial Income1 000
Financial Costs0
Financial Balance1 000
Earnings Before Tax123 000
Tax0
Net Income123 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets469 000
Total Assets469 000
Total Retained Equity147 000
Total Equity174 000
Total Long-Term Debt0
Total Current Debt295 000
Total Equity and Debt469 000
Cash flow (NOK)2022
Sales Income1 711 000
Other Income0
Revenue1 711 000
Cost of Goods Sold59 000
Salary Costs1 487 000
Depreciation0
Impairment0
Expenditure1 589 000
Operating Profit122 000
Financial Income1 000
Financial Costs0
Financial Balance1 000
Dividends0
Net Income123 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank317 000
Total Current Assets469 000
Total Assets469 000
Total Equity174 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors−16 000
Unpaid Taxes159 000
Dividends0
Other Current Debt152 000
Total Current Debt295 000
Total Equity and Debt469 000
Financial indicators2022
Return on Equity70,69 %
Debt-to-Equity Ratio0
Operating Profit Margin7,13 %
Current Ratio1,59
Quick Ratio1,59
Equity Ratio0,37
Gross Profit Margin96,55 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English